NEW YORK, Aug. 14, 2026 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE American: ATNM) (Actinium or the Company), a pioneer in the development of targeted radiotherapies, today announced advances across its Actimab-A program, including recently acquired patents adding to a broad...
Hence then, the article about actinium pharmaceuticals announces actimab a intellectual property and manufacturing advances and provides nyse american listing update was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Actinium Pharmaceuticals Announces Actimab-A Intellectual Property and Manufacturing Advances and Provides NYSE American Listing Update )
Also on site :
- Clarks’ ‘Comfortable’ Loafers Have Shoppers Walking ‘All Day With No Fatigue,’ and They’re on Sale for $60
- We Asked 3 Disney Travel Experts for the Best Multigenerational Family Vacation Upgrade—They All Said the Same Thing
- Ted Lasso's Jason Sudeikis And Brett Goldstein Team With Sesame Street's Elmo And Oscar For Daily Affirmations — Watch Or Scram!